Literature DB >> 8379691

Immunohistochemical localization of lipocortins in normal and psoriatic human skin.

K Ikai1, K Shimizu, Y Ando, F Furukawa, S Imamura, R Kannagi.   

Abstract

The distribution of lipocortin I, a steroid-induced inhibitory protein of phospholipase A2, was examined in normal and psoriatic human skin. Using immunoblotting analysis with specific antibody against human lipocortin I purified from human placenta, lipocortin I was detected as a 37 kDa protein in cultured epidermal cells, whole skin and epidermis. In the dermis and stratum corneum, lipocortin I was only weakly detectable by Western blotting. In contrast to normal skin, much less lipocortin I was detected by Western blotting analysis in psoriatic skin. Using immunoperoxidase immunohistochemical analysis, lipocortin I was demonstrated in the cytoplasm of keratinocytes in the upper and middle layers of the epidermis and in some infiltrating cells in the dermis in normal skin. In involved psoriatic skin, by contrast, lipocortin I was almost undetectable in the epidermis, although it was demonstrated in some infiltrating cells in the dermis. No immunostaining of lipocortin I was observed in the stratum corneum of normal or psoriatic skin. These results, together with the finding that phospholipase A2 activity is higher in psoriatic epidermis than in normal epidermis, suggest that lipocortin I plays an important role in the regulation of differentiation and proliferation of epidermal keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379691     DOI: 10.1007/bf00371600

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

1.  Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs.

Authors:  R A Fava; J McKanna; S Cohen
Journal:  J Cell Physiol       Date:  1989-11       Impact factor: 6.384

2.  Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent.

Authors:  A J Aarsman; G Mynbeek; H van den Bosch; B Rothhut; B Prieur; C Comera; L Jordan; F Russo-Marie
Journal:  FEBS Lett       Date:  1987-07-13       Impact factor: 4.124

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A monoclonal antibody specifically reactive to human Langerhans cells.

Authors:  M Kashihara; M Ueda; Y Horiguchi; F Furukawa; M Hanaoka; S Imamura
Journal:  J Invest Dermatol       Date:  1986-11       Impact factor: 8.551

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma.

Authors:  S M Violette; I King; J L Browning; R B Pepinsky; B P Wallner; A C Sartorelli
Journal:  J Cell Physiol       Date:  1990-01       Impact factor: 6.384

8.  Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema.

Authors:  S Forster; E Ilderton; J F Norris; R Summerly; H J Yardley
Journal:  Br J Dermatol       Date:  1985-02       Impact factor: 9.302

9.  The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation.

Authors:  F Hirata
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

10.  Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.

Authors:  F F Davidson; E A Dennis; M Powell; J R Glenney
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

View more
  2 in total

1.  Localization of annexin I (lipocortin I, p35) mRNA in normal and diseased human skin by in situ hybridization.

Authors:  K C Sato-Matsumura; H Koizumi; T Matsumura; A Ohkawara; T Takasu; Y Furuta; H Sawa; K Nagashima
Journal:  Arch Dermatol Res       Date:  1996-09       Impact factor: 3.017

Review 2.  Topical glucocorticoids and the skin--mechanisms of action: an update.

Authors:  A Ahluwalia
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.